Study tests which smoking warnings work best for different readers
NCT ID NCT00684437
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how smokers with different reading skills respond to various health messages about smoking risks. About 494 smokers will listen to and read messages that are either factual or emotional, and either highlight benefits of quitting or costs of not quitting. The goal is to see which message types increase smokers' intention to quit and improve their attitudes toward quitting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help design better smoking-cessation messages tailored to people with different literacy levels.
What could go wrong
This is an observational study with no treatment. Results may not directly help smokers quit, and the findings might not apply to all groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States